RxDoctor Payments Data

Gita Pillai, MD

Orthopaedic Surgery · Lewes, DENPI 1548428725

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (47.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Stryker at 45.7% of the total. Reporting peaked in 2021 at $1,769 and has fallen 69.9% since, to $533 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in DE, where the typical reported total is $6,222.

$5,813in general payments, 2019–2025

Across 41 payments — averaging $141.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Supreme Orthopedic Systems, LLC$3K
  • Smith+Nephew$494
  • Pacira Therapeutics, Inc.$55
  • Johnson & Johnson$37

What the payments were for

  • Travel & lodging$2,74147%
  • Food & beverage$1,87332%
  • Education$1,20021%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,813 in reported general payments places this provider in the 45th percentile of 70 orthopaedic surgery providers in Delaware.

See all orthopaedic surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$613,525
Medicare patients
1,425
Services billed
7,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam602$2,411
Prednisone113$1,512
Diclofenac Sodium ErDiclofenac Sodium23$817
Methylprednisolone83$564
Naproxen119$377
Oxycodone Hcl132$319
Celecoxib46$160
Mupirocin12$119
Gabapentin64$102
Amoxicillin81$62
Tramadol Hcl18$38
Diazepam15$14

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Lewes

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →